Dr. Cary Kaufman has lectured and published numerous articles on many aspects of the diagnosis and treatment of breast cancer both nationally and internationally. Dr. Kaufman is on the clinical faculty of the University of Washington and is the Medical Director of the Bellingham Breast Center. He is a member of the Society of Surgical Oncology, the American Society of Breast Surgeons, is a journal reviewer for the Journal of Surgical Oncology, and is on the National Ultrasound Faculty of the American College of Surgeons. Dr. Kaufman currently serves as the President of the National Consortium of Breast Centers.

 

Dr. Arnold Baskies is the Chief Medical Officer of the National Cancer Society’s Eastern Regional Division.  He provides medical advice and direction to the ACS and serves as a spokesmen to the public, legislators and the media.  He is also the Chairmen of the New Jersey Governor’s Task Force for Cancer Prevention, Early Detection and Treatment, which oversees the state implementation of the Comprehensive Cancer Control Plan and he is the NJ Chairmen of the Commission on Cancer’s Cancer Liaison Program.  Dr. Baskies a member of numerous medical societies, including the Society of Surgical Oncology, the American Society of Clinical Oncology, the American Society of Breast Surgeons, the Society for Surgery of the Alimentary Tract, and the Eastern Vascular Society. He has an abiding interest in all facets of breast cancer, and is the 1998 recipient of the Silver Chalice Award from the American Cancer Society. 

St. Vincent Medical Center works closely with the National Cancer Institute (NCI), the government agency that sets the standards for cancer treatment in the United States. NCI-affiliated hospitals are required to take part in an intensive review process, and only those conducting the most promising and leading-edge research are associated with this government agency.

Artann Laboratories brings world-leading expertise in soft tissue mechanics to the company. During the last decade Dr. Armen Sarvazyan has studied problems of breast and prostate cancer detection and developed numerous diagnostic methods and devices including the anatomical/physiological models and software technology that drive the SureTouch data processing. MTI and Artann Laboratories have established a strategic partnership agreement where MTI has exclusive rights to all present and future IP created by Artann relating to the breast field.

http://www.artannlabs.com